← Back to All Filings

Natera Exec Chairman Sells $16.4M in Shares via 10b5-1 Plan

Low SignificanceSeptember 12, 2026 at 1:37:26 AM UTC

Natera, Inc.

$NTRA4CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera Exec Chairman Sells $16.4M in Shares via 10b5-1 Plan

Company: Natera, Inc. (NTRA) Form: 4 | Filed: 2026-09-12 Significance: Low

Insider: Matthew Rabinowitz Title: Executive Chairman | Relationship: Director / Officer

Transaction: • Type: Disposition (Sale) • Shares: 50,000 • Price: ~$327.96 (weighted avg) • Total Value: $16,398,101.16 • Owned After: 2,225,394 direct shares

Key Insight: Executive Chairman Matthew Rabinowitz disposed of 50,000 shares ($16.4M) pursuant to a pre-scheduled Rule 10b5-1 plan adopted in June 2026, trimming his direct stake by ~2.2% while retaining over 2.22M shares.

Market Context: Relative to Natera's $47.18B market capitalization, the transaction accounts for 0.035% of total shares outstanding, representing routine executive liquidity.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Executive Chairman Matthew Rabinowitz sold 50,000 shares (~$16.40 million) pursuant to a pre-arranged Rule 10b5-1 trading plan.
  • Market Impact: Neutral; routine programmatic sale representing 0.035% of shares outstanding.

Company Information

FieldValue
CompanyNatera, Inc.
Ticker SymbolNTRA
CIK0001604821
IndustryServices - Medical Laboratories

Insider Information

FieldValue
NameMatthew Rabinowitz
CIK0001646382
Title/PositionExecutive Chairman
RelationshipDirector / Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-09-11
Transaction CodeS (Open Market Sale)
Security TypeCommon Stock
Shares Involved50,000
Price Per Share$327.96 (Weighted Average)
Total Value$16,398,101.16
Shares Owned After2,225,394 (Direct)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$16,398,101.16
% of Market Cap0.035%
Shares Transacted50,000
% of Shares Outstanding0.035%
Post-Transaction Ownership2,225,394 direct shares (1.55% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Against Natera's $47.18 billion market capitalization, the $16.40M transaction is minor (<0.1% of market cap), reflecting normal diversification.
  • Ownership Concentration: The insider maintains substantial ownership of 2,225,394 direct shares and 2,000 indirect shares (via spouse), representing ~1.55% of total shares outstanding.
  • Transaction Significance: The sale disposed of approximately 2.20% of the insider's total direct position under a pre-established plan, showing continued strong alignment with long-term company performance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The trade was executed under a Rule 10b5-1 plan established on June 12, 2026, and constitutes a negligible percentage of float and market cap.

Volume & Sentiment

  • Expected Volume Impact: Negligible; 50,000 shares transacted in multiple structured blocks across the trading session.
  • Sentiment Indicator: Neutral

Additional Context

Transaction Notes

  • Timing: Executed on September 11, 2026, across prices ranging from $324.49 to $329.74.
  • Special Circumstances: Fully executed pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026.
Topics:#SECFiling#NTRA#Natera#Form4#InsiderTrading#InsiderSell#StockMarket#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.